FDA issues warning against the cough medicine Tussionex
The US FDA has just issued a safety alert concerning the long-acting cough depressant Tussionex Pennkinetic Extended-Release Suspension. Its use has been associated with side effects, some of which are life-threatening, both in adults and children.
Some of the warnings issued by the FDA are:
? Tussionex should not be prescribed to children under 6 years old.
? Doctors should clearly explain to the patient or parents of the patient (if the patient is a minor) the correct dosing amount and frequency.
? The drug should not be taken too frequently – an interval of 12 hours or more should separate each dose.
? Proper measuring devices such as a medicine syringe should be used when measuring the medicine. Do not use an ordinary teaspoon or tablespoon.
Tussionex contains the narcotic hydrocodone and the antihistamine chlorpheniramine. Hydrocodone can be dangerous when taken in overdose. Some of the adverse effects associated with this medicine are:
? Breathing problems
? Slow heartbeat
? Cold clammy skin